LexaGene Intends to Pursue Full Panel Pathogen Testing through the FDA

NEXT STORY
Valeo Pharma Announces Upsize of Previously Announced Bought Deal Private Placement of Convertible Debentures to $15 Million With Concurrent $10 Million Private Placement From Investissement Quebec
PREV STORY
Global Materiovigilance Market to Surpass US$ 113.5 Billion by 2028, Says Coherent Market Insights (CMI)
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Argos Therapeutics Reports Second Quarter 2016 Financial Results and Recent Operational Highlights

- Independent Data Monitoring Committee Recommended Continuation of Phase 3 ADAPT Trial of AGS-003 ...

author_avatar
NASDAQ Market News

Final patient receives treatment in stem cell clinical trial for severe blood cancers

MONTREAL, June 27, 2018 (GLOBE NEWSWIRE) -- ExCellThera Inc., a biotechnology company delivering molecules ...

author_avatar
NASDAQ Market News

Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial

Benefit Observed at 12 months Postoperatively Following Single AdministrationSAN DIEGO, July 09, 2018 (GLOBE ...

author_avatar
NASDAQ Market News